The method comes from doing the work.
Twenty years commercializing more than twenty FDA-cleared technologies across medical device, diagnostics, and digital health.
Where the pattern came from.
A career built across DuPont, GE Healthcare, Siemens Healthineers, Primasun, and CINQCARE.
At GE Healthcare, took the Pristina mammography platform from single-digit share to number two in its category in eighteen months, recognized with the GE Chairman's Award. Also led a global sales transformation grounded in more than 1,500 customer interviews across 14 countries.
At Primasun, the ResMed and Verily-backed sleep health venture, built a category presence from nothing to more than 328 media syndications.
The same failure, over and over.
Across those two decades the pattern repeated. Good technology cleared regulatory review, launched, and then did not get used. The reasons were rarely the ones the company believed. The Adoption Diagnosis™ is the instrument built to find the real one.
The Diagnosis carries the full argument.
Also.
PhD in Chemistry from Penn State and a BS from Howard University. Board service with the Brem Foundation to Defeat Breast Cancer and the Jamaica Howard University Affinity Network, and regional leader for Women Executives on Boards. Harvard Women on Boards alum and a Johnson and Johnson Innovation Board Fellow. Writing published in Fortune and Fast Company. Speaks on adoption, commercialization, and why cleared technology stalls; inquiries through the contact address below.
Start with a Fit Check.
A short, free conversation that confirms there is enough evidence to run the diagnosis, and whether now is the right time.